Guru Ownership Trend
Guru Analysis for Aktis Oncology, Inc. (AKTS)
Aktis Oncology, Inc. (AKTS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $6.09 M.
Top institutional holders include George Soros and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $4.63 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Aktis Oncology, Inc. (AKTS)
Major holders include George Soros ($3.22 M), Renaissance Technologies (RenTech) ($3.07 M), Cliff Asness ($1.55 M). According to the latest reported data, 3 tracked investment managers collectively hold approximately 243,523 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $4.63 M, with 2 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in AKTS during the most recent reporting period.
Yes, 2 managers opened new positions in AKTS, and 0 increased their existing holdings. The total reported buy value was $4.63 M.